The Archer FusionPlex Heme v2 Kit is an RNA-based targeted sequencing assay that detects and identifies fusions of 87 genes associated with hematological malignancies. Using Archer’s proprietary Anchored Multiplex PCR-based enrichment (AMPTM),
fusions of all genes in this kit can be identified in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints. Additionally, select genes are targeted for molecular barcode-enabled relative expression level
detection and point mutation coverage.